Citadel Advisors - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 4 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$8,618,000
+0.7%
60,400
-9.3%
0.01%
-9.1%
Q1 2016$8,556,000
+93.5%
66,600
+125.0%
0.01%
+120.0%
Q4 2015$4,421,000
-0.9%
29,600
+10.0%
0.01%
+25.0%
Q3 2015$4,462,000
-26.4%
26,900
+7.2%
0.00%
-20.0%
Q2 2015$6,059,000
-59.5%
25,100
-52.6%
0.01%
-64.3%
Q1 2015$14,947,000
+185.1%
53,000
+57.7%
0.01%
+180.0%
Q4 2014$5,242,000
-24.9%
33,600
+13.9%
0.01%
-28.6%
Q3 2014$6,982,000
+17.6%
29,500
+17.5%
0.01%0.0%
Q2 2014$5,939,000
-34.0%
25,100
-8.1%
0.01%
-36.4%
Q1 2014$9,003,00027,3000.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 71,700$962,9310.00%
JANE STREET GROUP, LLC 104,000$1,396,7200.00%
SIMPLEX TRADING, LLC 58,400$7840.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders